NTLA
Intellia Therapeutics, Inc · Health Care · NASDAQ
$17.56
▲ $0.32 (+1.86%)
Market cap
$2.2B
52-week range
$7.95 – $28.25
Volume
5.1M
Previous close
$17.24
Intellia Therapeutics, Inc (NTLA) is held by 2 tracked hedge fund(s). Sector: Health Care. Largest tracked holder: ARK Investment Management LLC.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| ARK Investment Management LLC Cathie Wood |
1.4% | 14.5M | $186M | ▲ 2.1% (+302K) | $29.26 | 2026-03-31 |
| Contrarius Investment Stephen Mildenhall |
2.4% | 2.0M | $42M | ▲ 6.9% (+132K) | $27.04 | 2024-09-30 |
FAQ ▾
Which hedge funds hold NTLA?
Tracked holders include: ARK Investment Management LLC, Contrarius Investment.
How much smart money owns NTLA?
2 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading NTLA?
No tracked Congressional trades in NTLA on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings · Not investment advice ▾
Ownership from SEC filings; price from market data.
Published by WealthFile · Not investment advice.